This 6-day in person course spread over 6 sessions , aims to provide a robust grounding in all aspects of pharmacology and therapeutics in palliative medicine. The course material is evidence based where possible so that participants become acquainted with the body of literature that relates to practice in this field.
Days 1, 2 and 3 will be framed around the World Health Organisation analgesic ladder and will enable participants to gain an in depth understanding on pain physiology and the pharmacology of step I, II and III drugs and co-analgesics, current evidence base, and application in clinical practice. Additionally, over the 3 days we will cover specialist topics from expert speakers such as management of seizures, bone metastases, update on immunotherapy and malignant spinal cord compression.
Days 4, 5 and 6 will be broadly themed. We will explore the common metabolic and endocrine abnormalities relevant to palliative care and the management of these conditions including hypercalaemia, diabetes management at the end of life. We will then look at evidence based guidance and management of nausea and vomiting, constipation and malignant bowel obstruction. Lastly, we will enhance our understanding on pharmacological management of anxiety, depression and terminal agitation as we look at evidence based guidance.
Participants will also benefit from an additional range of specialist topics over the 3 days by our expert speakers including prescribing in patients with liver failure, renal impairment, recognition and management of delirium.
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube